T139-0313 Screening compound: 1-(1-cyclopentanecarbonylpiperidin-4-yl)-5-oxo-N-(propan-2-yl)pyrrolidine-2-carboxamide

T139-0313 Screening compound: 1-(1-cyclopentanecarbonylpiperidin-4-yl)-5-oxo-N-(propan-2-yl)pyrrolidine-2-carboxamide
T139-0313 Screening compound: 1-(1-cyclopentanecarbonylpiperidin-4-yl)-5-oxo-N-(propan-2-yl)pyrrolidine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T139-0313
1-(1-cyclopentanecarbonylpiperidin-4-yl)-5-oxo-N-(propan-2-yl)pyrrolidine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T139-0313

Molecular Formula

C19H31N3O3 (C19 H31 N3 O3)

Compound Name

1-(1-cyclopentanecarbonylpiperidin-4-yl)-5-oxo-N-(propan-2-yl)pyrrolidine-2-carboxamide

IUPAC name

1-(1-cyclopentanecarbonylpiperidin-4-yl)-5-oxo-N-(propan-2-yl)pyrrolidine-2-carboxamide

SMILES

CC(C)NC(C(CC1)N(C(CC2)CCN2C(C2CCCC2)=O)C1=O)=O

InChI

InChI=1S/C19H31N3O3/c1-13(2)20-18(24)16-7-8-17(23)22(16)15-9-11-21(12-10-15)19(25)14-5-3-4-6-14/h13-16H,3-12H2,1-2H3,(H,20,24)/t16-/m1/s1

InChI Key

VEGGTBXLDGLWJY-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD31984254

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

349.47

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.537

Distribution Coefficient, logD

1.537

Water Solubility, LogSw

-1.77

Polar Surface Area

56.909

Acid Dissociation Constant (pKa)

14.92

Base Dissociation Constant (pKb)

2.56

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

84.21

T139-0313 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with T139-0313 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T139-0313?
Check Price and Availability of T139-0313, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T139-0313 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T139-0313
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T139-0313
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T139-0313 available by request